Serina Therapeutics, Inc.
SER
$5.65
$0.152.73%
AMEX
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -12.59M | -939.00K | -11.14M | -7.35M | -7.01M |
| Total Depreciation and Amortization | 145.00K | 186.00K | 194.00K | 144.00K | 142.00K |
| Total Amortization of Deferred Charges | 16.00K | 323.00K | 345.00K | 337.00K | 329.00K |
| Total Other Non-Cash Items | -5.13M | -15.89M | -3.06M | -2.00M | 600.00K |
| Change in Net Operating Assets | 1.93M | -3.56M | -3.48M | -3.56M | -4.55M |
| Cash from Operations | -15.62M | -19.88M | -17.14M | -12.43M | -10.49M |
| Capital Expenditure | -54.00K | -8.00K | -22.00K | -87.00K | -203.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -54.00K | -8.00K | -22.00K | -87.00K | -203.00K |
| Total Debt Issued | 118.00K | 643.00K | 3.04M | 2.93M | 2.93M |
| Total Debt Repaid | -9.00K | -155.00K | -168.00K | -180.00K | -184.00K |
| Issuance of Common Stock | 10.58M | 10.00M | 10.00M | 5.08M | 5.01M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 4.92M | 4.92M | 337.00K | 337.00K | 337.00K |
| Cash from Financing | 15.60M | 15.40M | 13.21M | 8.17M | 8.08M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -73.00K | -4.49M | -3.95M | -4.35M | -2.61M |